Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in cdsco

Percentage Of Spurious Drug Samples Showing Consistent Decline: Mandaviya

As per information available from various state licensing authorities, in cases of fake and spurious COVID management drugs, various enforcement actions like drug seizure, arrests of accused persons, registration of FIRs etc have been carried out by the state/UT drugs controllers

Read More

11% Of India's Covid-19 Cases Reported In Persons Aged Below 20: Govt

The outcome of these trials will depend on data emerging from the trial for the purpose of its approval and availability in the country

Read More

Several Steps Taken To Enhance Manufacturing Of COVID Vaccines: Mandaviya

The government has launched 'Mission COVID Suraksha- The Indian COVID-19 Vaccine Development Mission' that is being implemented by Biotechnology Industry Research Assistance Council (BIRAC) of Department of Biotechnology

Read More

Laurus Labs Receives Licence From DRDO To Manufacture And Market COVID Drug 2DG

Shares of Laurus Labs were trading at Rs 674.20 per scrip on BSE, up 1.08 per cent from the previous close.

Read More

New Segment In The Opening- Phytopharmaceuticals

Industry leaders in herbal products are putting several efforts at industry scale to convert Ayurvedic aqueous extract to a phytopharmaceutical with the help of technology-based approaches which will further generate great opportunities in this area.

Read More

Bharat Biotech's Covaxin Gets Approval For Phase 2/3 Trials On Children Aged 2 To 18

The trial will be conducted in 525 subjects at different locations, including AIIMS Patna, AIIMS Delhi and Meditrina Institute of Medical Sciences in Nagpur.

Read More

Natco Seeks CDSCO Approval For Phase-III Trial Of Molnupiravir For COVID-19 Treatment

Natco Pharma has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of phase-III clinical trial of Molnupiravir capsules for the treatment of COVID-19 positive patients

Read More

SEC recommends Dr Reddy's to submit additional data for EUA of Sputnik V COVID vaccine

SEC recommends Dr Reddy's to submit additional data for EUA of Sputnik V COVID vaccine

Read More

Approval to Covaxin premature, could be dangerous: Tharoor

Approval to Covaxin premature, could be dangerous: Tharoor

Read More

COVID-19: Expert committee recommends restricted emergency use of SII, Bharat Biotech's vaccines

COVID-19: Expert committee recommends restricted emergency use of SII, Bharat Biotech's vaccines

Read More

India Approves AstraZeneca's COVID-19 Vaccine

India's Central Drugs Standard Control Organization (CDSCO) is expected to announce the dosage and other details about the shot later. SII had applied for a two full-dose regime about 28 days apart.

Read More

India Drug Regulator Meets To Discuss Astrazeneca Vaccine

India wants to start administering the shots starting next month and is also considering emergency use authorisation applications for vaccines made by Pfizer Inc with Germany's BioNTech and by India's Bharat Biotech.

Read More

DCGI's expert panel recommends Phase 3 clinical trial nod for Bharat Biotech's Covid-19 vaccine

DCGI's expert panel recommends Phase 3 clinical trial nod for Bharat Biotech's Covid-19 vaccine

Read More

Drugs control organisation issues guidelines for trial, marketing of vaccines

Drugs control organisation issues guidelines for trial, marketing of vaccines

Read More

MTaI Welcomes CDSCO Notice Addressing Challenges And Furthering Ease Of Doing Business For Medical Device Sector

This pace is further slowed because of the several operational bottlenecks which continue to impede smooth functioning of business.

Read More